Comment on

• Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.

  Anzalone N, Scarabino T, Venturi C, Cristaudo C, Tartaro A, Scotti G, Zimatore D, Floris R, Carriero A, Longo M, Cirillo M, Cova MA, Gatti S, Voth M, Colosimo C. Anzalone N, et al. Eur J Radiol. 2013 Jan;82(1):139-45. doi: 10.1016/j.ejrad.2011.07.005. Epub 2011 Sep 3. Eur J Radiol. 2013. PMID: 21890295 Clinical Trial.